Composition
- Active ingredients
- APREPITANT 130MG/18ML
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- APREPITANT 32MG/4.4ML (7.2MG/ML) · EmulsionANDA218851-001 · Discontinued
- APREPITANT 125MG · CapsuleANDA090999-003 · Prescription
- APREPITANT 40MG · CapsuleANDA090999-001 · Prescription
- APREPITANT 80MG · CapsuleANDA090999-002 · Prescription
- APREPITANT 130MG/18ML (7.2MG/ML) · InjectableNDA218754-001 · Tentative approval
- APREPITANT 130MG/18ML · Injection, emulsionThis page
- APREPITANT 125MG · CapsuleANDA211835-003 · Prescription
- APREPITANT 40MG · CapsuleANDA211835-001 · Prescription
- APREPITANT 80MG · CapsuleANDA211835-002 · Prescription
- APREPITANT 80MG · CapsuleANDA207777-002 · Prescription
- APREPITANT 125MG · CapsuleANDA207777-003 · Prescription
- APREPITANT 40MG · CapsuleANDA207777-001 · Prescription
Official product information
At a glance
- Brand name
- Aprepitant
- Dosage form
- Injection, emulsion
- Applicant
- Mylan Pharmaceuticals Inc
- Status
- Tentative approval
- FDA approval
- 17 Nov 2025
- Application
- ANDA216976-001